Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

Specimen Handling 5Human Papillomavirus Recombinant Vaccine nonavalent 4Papillomavirus Vaccines 3Human Papillomavirus DNA Tests 3Colposcopy 3Radiotherapy, Intensity-Modulated 2Methods 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Early Intervention, Educational 2Cisplatin 2human papillomavirus vaccine, L1 type 16, 18 1artesunic acid 1artenimol 1artemisinin 1adacel 1Vaccines 1Tetanus Toxoid 1Sodium Chloride 1Platinum 1Patient Navigation 1Nimorazole 1Mass Screening 1Interviews as Topic 1Injections 1High-Energy Shock Waves 1Educational Status 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Clinical Protocols 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Papillomavirus Infections × artesunic acid × Clear all
NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting
17 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡